Dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders

CEGIR Mission Statement

The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) is dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders through innovative research, clinical expertise and education via collaborations between scientists, health care providers, patients, and professional organizations.

Dr. Marc Rothenberg, MD, PhD poses with a CEGIR patient who wears a mask that reads, "Hero"

Join One of Our Research Studies

Participants make it possible for researchers to find new treatments, speed diagnosis, and improve the lives of those affected by rare diseases

Find a Study

See Our Clinical Sites

Learn About Diseases We Study

Find Funding Opportunities

Read Our Research

Rare Research Report: October 2024

Each month, we share summaries of recent Rare Diseases Clinical Research Network (RDCRN) grant-funded publications.

Eosinophilic Gastrointestinal Diseases Over Time: What We’re Learning from a Natural History Study

To learn more about eosinophilic gastrointestinal diseases, the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) is conducting a natural history study, “Outcome Measures for Eosinophilic Gastrointestinal Diseases across Ages (OMEGA).”

Podcast: Eosinophilic Gastrointestinal Disorders: A New Path

Listen to this episode of the Pediatric and Developmental Pathology podcast.

Get to Know Us

Learn more about CEGIR, one of 20 consortia funded by the National Institutes of Health through the Rare Diseases Clinical Research Network. Together, we are working to better understand how Eosinophilic Gastrointestinal Diseases progress and to develop improved approaches for diagnosis and treatment.

Watch Now